(BHF) Brighthouse Financial - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US10922N1037
BHF: Annuities, Life Insurance, Structured Settlements
Brighthouse Financial, Inc. (NASDAQ: BHF) is a U.S.-based financial services company specializing in annuity and life insurance products. Established in 1863, the firm has a long-standing presence in the insurance industry. Headquartered in Charlotte, North Carolina, Brighthouse operates through three distinct business segments: Annuities, Life, and Run-off.
The Annuities segment offers a range of products, including variable, fixed, index-linked, and income annuities. These products are designed to meet contract holders needs for tax-deferred wealth accumulation, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life insurance policies, catering to policyholders seeking financial security and protected wealth transfer solutions.
The Run-off segment is focused on managing legacy products, including structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life policies with secondary guarantees. This segment is essentially winding down older, less core businesses, optimizing capital allocation, and reducing operational complexity.
Brighthouse Financial, Inc. is listed on the NASDAQ exchange under the ticker symbol BHF. As of recent data, the company has a market capitalization of approximately $3.44 billion. Its trailing P/E ratio stands at 12.04, with a forward P/E of 3.03, indicating expectations of significant earnings growth. The price-to-book (P/B) ratio is 0.69, suggesting the market values the company below its book value, while the price-to-sales (P/S) ratio of 0.71 reflects its valuation relative to revenue.
For investors and fund managers, Brighthouse Financials diversified product portfolio and focus on de-risking its balance sheet are key considerations. The companys ability to manage its run-off businesses while growing its core annuity and life insurance segments will be critical to its long-term profitability and shareholder value creation.
Additional Sources for BHF Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BHF Stock Overview
Market Cap in USD | 3,444m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2017-07-17 |
BHF Stock Ratings
Growth 5y | 34.9% |
Fundamental | -29.6% |
Dividend | 0.0% |
Rel. Strength Industry | -4.36 |
Analysts | 2.7/5 |
Fair Price Momentum | 57.24 USD |
Fair Price DCF | 11.04 USD |
BHF Dividends
No Dividends PaidBHF Growth Ratios
Growth Correlation 3m | 48% |
Growth Correlation 12m | 37.3% |
Growth Correlation 5y | 50.6% |
CAGR 5y | 6.62% |
CAGR/Max DD 5y | 0.11 |
Sharpe Ratio 12m | 0.67 |
Alpha | 8.34 |
Beta | 0.78 |
Volatility | 33.44% |
Current Volume | 632.6k |
Average Volume 20d | 1057.7k |
As of February 23, 2025, the stock is trading at USD 59.45 with a total of 632,609 shares traded.
Over the past week, the price has changed by -4.33%, over one month by +15.46%, over three months by +17.84% and over the past year by +24.37%.
Probably not. Based on ValueRay Fundamental Analyses, Brighthouse Financial (NASDAQ:BHF) is currently (February 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -29.55 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BHF as of February 2025 is 57.24. This means that BHF is currently overvalued and has a potential downside of -3.72%.
Brighthouse Financial has received a consensus analysts rating of 2.70. Therefor, it is recommend to hold BHF.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 1
- Strong Sell: 2
According to ValueRays Forecast Model, BHF Brighthouse Financial will be worth about 62.1 in February 2026. The stock is currently trading at 59.45. This means that the stock has a potential upside of +4.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 60.3 | 1.3% |
Analysts Target Price | 52.4 | -11.9% |
ValueRay Target Price | 62.1 | 4.5% |